FDA’s Initial Draft Guidance on Clinical Trials with Psychedelic Drugs

psychedelics clinical trials

The U.S. Food and Drug Administration released a new draft guidance for researchers looking into psychedelic medicines to potentially treat medical illnesses, such as psychiatric or substance use disorders, highlighting important factors. This is the first FDA draft guidance offering industry advice on planning clinical trials for psychedelic medications. In recent years, there has been an increase

Read More >

New York’s OCM Updates Illegal cannabis enforcement plan

new york cannabis enforcement plan

The New York State Office of Cannabis Management provided an update on their increased efforts to battle the illegal cannabis industry in the state at the meeting today. As part of the FY 2024 Budget, Governor Hochul approved legislation on May 3, 2023, permitting increased enforcement by OCM against unauthorized cannabis enterprises. The law now allows OCM

Read More >

New York OCM changes for dispensaries to open faster

New York announces program changes for stores to open faster

The new initiatives that were announced will help support cannabis entrepreneurs by lowering costs and fast track the application process so social justice licensees. On June 15th, the Cannabis Control Board will issue the first licenses to qualified Adult-Use Retail applicants. Two additional adult-use cannabis dispensaries will soon open in Farmingdale and Syracuse, according to the

Read More >